Omicron symptoms less severe than Delta variant – study

The research found the incubation time and period of infectiousness for Omicron is shorter than for previous variants.

Nina Massey
Thursday 07 April 2022 23:30
Symptoms of Omicron are on average less severe than the Delta variant (Dominic Lipinski/PA)
Symptoms of Omicron are on average less severe than the Delta variant (Dominic Lipinski/PA)

People who have Omicron are more likely to have a sore throat and less likely to lose their smell compared to Delta, a new study has found.

The research indicates people are also less likely to be admitted to hospital with the current dominant variant and that symptoms do not last as long in those who have been vaccinated than with Delta (6.87 days versus 8.89 days).

The findings support previous studies that suggest the incubation time and period of infectiousness for Omicron is shorter than for previous coronavirus variants.

We observe a different clinical presentation of symptoms in those infected with Omicron compared to Delta

Dr Cristina Menni

According to the research, the biggest difference was in the loss of sense of smell, which appeared in 52.7% of Delta cases, and showed up in less than 20% of Omicron cases.

The two Covid-19 symptoms that were consistently more prevalent in both variants – regardless of vaccination status – were a sore throat and hoarse voice.

Researchers also found that some of the more debilitating symptoms, such as brain fog, eye burning, dizziness, fever and headaches were significantly less prevalent in Omicron cases.

Dr Cristina Menni from King’s College London said: “We observe a different clinical presentation of symptoms in those infected with Omicron compared to Delta.

“As we are moving even further away from the average patient having UK government ‘core’ symptoms ie fever, persistent cough, loss of smell, our results point to a different selection of symptoms that may indicate infection.

(PA Graphics)

“To protect others, it is still important to self-isolate for five days as soon as you see any symptoms.”

Professor Ana Valdes, an honorary professor at King’s College London, said: “Although there is still a wide range of duration and severity of symptoms with Omicron, for vaccinated individuals we find on average a shorter duration of symptoms.

“This suggests that the incubation time and period of infectiousness for Omicron may also be shorter.”

Researchers from King’s College London and scientists from Zoe studied the symptoms of 62,002 vaccinated UK participants from the Zoe Covid Study App who tested positive between June 1 last year and November 27 2021, when Delta was dominant, and December 22 2021 to January 17 this year when Omicron was dominant.

The study will be presented at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) this month in Lisbon.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in